<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

Michael S. Binkley(Palo Alto University), Maximilian Diehn(Stanford University), Siyeon Rhee(Cardiovascular Institute of the South), Billy W. Loo(Princess Margaret Cancer Centre), Young-Jun Jeon(Stanford University), Kavitha Ramchandran(Stanford University), Barzin Y. Nabet(Gene Therapy Laboratory), Michael Xiang(University of California, Los Angeles), Everett J. Moding(Stanford Medicine), Emily G. Hamilton(Stanford University), Joel W. Neal(Stanford Medicine), Heather A. Wakelee(Palo Alto Institute), Monica Nesselbush(Human Genome Sciences (United States)), Christopher H. Yoo(Stanford University), Henning Stehr(Stanford University), Susie Grant Owen(Stanford Medicine), Ryan B. Ko(Stanford University), Sukhmani K. Padda(Stanford University), Millie Das(VA Palo Alto Health Care System), Peter G. Maxim(University of California, Irvine), Christian A. Kunder(Stanford University), Linda Gojenola(Stanford University), David M. Kurtz(Stanford University), Jacob J. Chabon(Foresight Science & Technology (United States)), June Ho Shin(Cancer Prevention Institute of California), Diego Almanza(Stanford University), Leah M. Backhus(Stanford University), Natalie S. Lui(Stanford University), Joseph B. Shrager(Stanford Medicine), Mark F. Berry(Stanford Medicine), Ash A. Alizadeh(California Institute for Regenerative Medicine)
Cancer Discovery
October 18, 2020
Cited by 172


Related Papers